CME 2481.html

Case reports


Acute coronary syndrome due to coronary vasospasm associated with thyrotoxicosis

The cardiovascular manifestations of hyperthyroidism are well known.1 , 2 It is less well recognised that angina may be due to coronary spasm caused by hyperthyroidism in a small subset of patients.1

I report on a patient who presented with angina and hyperthyroidism in whom repeated coronary angiography revealed coronary vasospasm. The suggested mechanism of the coronary vasospasm is thyrotoxicosis due to Graves’ disease.

Case report

A 37-year-old mother of two was referred with a 1-day history of severe ischaemic-type chest pain occurring at rest and associated autonomic symptoms of nausea, vomiting and excessive sweating. This pain was preceded by a 1-month history of intermittent chest pain. She had a background of diabetes mellitus and untreated hypertension. She also had a significant smoking history of 15 pack-years. On examination her blood pressure was 189/109 mmHg and her heart rate was 96 beats/min. Her systemic examination was unremarkable. A resting electrocardiogram (ECG) revealed sinus tachycardia with a rate of 126 beats/min, normal QRS axis, widespread ST-segment depression in the limb and precordial leads, with ST-segment elevation in the augmented unipolar limb lead (right arm) – aVR. At that time a transient run of atrial fibrillation was noted on the cardiac monitor and, on direct questioning, the patient reported having palpitations, heat intolerance, emotional lability and weight loss of 20 kg in the preceding six months. Laboratory testing showed: troponin-T 0.42 (normal <0.03), thyroid-stimulating hormone (TSH) <0.01, and thyroxine (T4) >100. The haemoglobin was normal and her pregnancy test was negative. She was assessed as having thyrotoxicosis with non-ST-segment elevation myocardial infarction (NSTEMI) and was treated with an infusion of unfractionated heparin, aspirin, simvastatin, atenolol, Lugol’s iodine, carbimazole and cholestyramine. The pain resolved on this treatment. Several hours later the pain recurred and therefore coronary angiography was done. This demonstrated severe stenosis of the left main stem. A decision to perform emergency coronary artery bypass graft surgery was made. However, the possibility of coronary vasospasm was strongly considered and consequently surgery was cancelled. It was decided that the treatment of thyrotoxicosis be continued, with angiography repeated later. She was subsequently diagnosed with Graves’ disease.

With treatment of hyperthyroidism the symptoms resolved and her T4 levels fell. On day 9 coronary angiography was repeated; severe left main stem stenosis was still present. She was euthyroid at that stage. The beta-blocker was stopped and nitrates and dihydropyridine calcium-channel blockers were added to the treatment regimen. Angiography was done again on day 12, with a marked improvement in the calibre of the vessel. Subsequent ECGs revealed resolution of the initial changes and the patient remained pain free at discharge on day 18. She has been followed up closely in the cardiac clinic and had a normal exercise ECG. She remains euthyroid and symptom free.

Discussion

This report highlights a case of thyrotoxicosis due to Graves’ disease causing coronary vasospasm and NSTEMI – the first report of its kind in South Africa.

Angina has been found to be associated with thyrotoxicosis in up to 25% of patients in one series.3 In patients with coronary atheroma, the presence of angina reflects a mismatch between myocardial oxygen supply and demand due to the increase in cardiac workload and contractility associated with thyrotoxicosis.1 , 4 Al Suwaidi et al. 5 documented 18 published reports, with a total of 34 patients, of angina pectoris associated with coronary spasm due to thyrotoxicosis, that have been confirmed angiographically since 1979. They found that the cardiac presentation varied from angina and myocardial infarction to ventricular arrhythmias, cardiogenic shock and cardiac arrest. They also noted that in these patients the manifestations of hyperthyroidism were either scarce or absent, which was also noted in the patient presented above.

Choi et al. 6 carried out a retrospective analysis of 325 patients presenting with coronary spasm between 1994 and 2000 in Korea. They reported that of these, 8 had hyperthyroidism due to Graves’ disease. In three patients, the left main stem coronary artery was involved in the spasm. Among these patients, five were female, and all the female patients were below the age of 51. All of these patients were treated with anti-thyroid medication, calcium-channel blockers, and long-acting nitroglycerines. They remained free of chest pain during the median follow-up period of five years. Resolution of chest pain with anti-thyroid treatment has also been reported by other authors.5

The mechanism of coronary vasospasm in hyperthyroidism remains unknown.

Conclusion

Hyperthyroidism should be considered in the differential diagnosis of chest pain due to coronary spasm, particularly in young women. Thyroid function tests should be routine in patients presenting with chest pain due to coronary spasm.

Chishala Chishala, MB ChB

2nd-year Registrar, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town

Correspondence to: C Chishala (chishala.chishala@gmail.com)


References

1. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344(7):501.

1. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344(7):501.

2. Klein I. Endocrine disorders and cardiovascular disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Libby Braunwald Heart Disease. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2008.

2. Klein I. Endocrine disorders and cardiovascular disease. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Libby Braunwald Heart Disease. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2008.

3. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations before and after antithyroid therapy. J Am Col Cardiol 2007;49:71-81.

3. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations before and after antithyroid therapy. J Am Col Cardiol 2007;49:71-81.

4. Kahaly GJ, Dillman WH. Thyroid hormone action in the heart. Endocrine Rev 2005;26:704-728.

4. Kahaly GJ, Dillman WH. Thyroid hormone action in the heart. Endocrine Rev 2005;26:704-728.

5. Al Suwadi J, Jihad A, Haque S, Noor H, Ibrahim B. Thyrotoxicosis and coronary artery spasm: case report and review of the literature. Angiology 2010;61(8):807-812.

5. Al Suwadi J, Jihad A, Haque S, Noor H, Ibrahim B. Thyrotoxicosis and coronary artery spasm: case report and review of the literature. Angiology 2010;61(8):807-812.

6. Choi Y, Chung JH, Bae SW, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coronary Artery Dis 2005;16(3):135-139.

6. Choi Y, Chung JH, Bae SW, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coronary Artery Dis 2005;16(3):135-139.

Article Views

Abstract views: 1467
Full text views: 3905

Comments on this article

*Read our policy for posting comments here